Vibrant young woman recovering from cancer with headline

Vibrant young woman recovering from cancer with headline Alter

the cancer landscape

Healthy senior man with sunset behind him

Redefining precision oncology,
one
alteration at a time

We are a clinical-stage precision oncology company focused on discovering and developing alteration-specific therapeutics to address oncogenic drivers. Combining deep expertise in biology, chemistry and computational drug design, we are advancing a pipeline of KRAS-targeted therapies with the potential to address significant unmet needs across multiple cancers, including colorectal and pancreatic cancers.

Our lead product candidate, ALTA3263, is a KRAS-selective, pan-mutant (ON/OFF) inhibitor designed to target a broad range of KRAS mutations.

Redefining KRAS treatment

We are developing next-generation KRAS-targeted therapies designed to overcome the limitations of existing treatment approaches and expand therapeutic opportunities across multiple cancers and treatment settings.

Explore our approach

Clinical-stage pipeline

We are continuing to advance ALTA3263 in a Phase 1/1b clinical trial in KRAS-mutant advanced solid tumors.

Discover our pipeline

World-class team

Our mission-driven team has a proven track record of delivering small molecule oncology drugs to patients in need.

Meet our leaders

News

OCTOBER 27, 2026
Alterome Therapeutics to Present First Clinical Data from Phase 1/1b Trial of ALTA3263 in KRAS-Mutant Advanced Solid Tumors in Late-Breaking Presentation at the 38th EORTC-NCI-AACR Symposium
Late-breaking oral presentation to showcase preliminary safety, tolerability, clinical activity, and pharmacokinetics data of ALTA3263 in monotherapy and in combination with cetuximab
SEPTEMBER 8, 2026
Alterome Therapeutics Appoints Johanna Mylet as Chief Financial Officer
Former Poseida Therapeutics CFO joins Alterome Therapeutics as the company prepares to accelerate development of KRAS-targeting medicines
Team photo of Alterome employees

Our people make the difference!

If you share our vision to transform the lives of people with cancer, come join us.

LEARN MORE
Best Places to Work icon 2023
Best Places to Work icon 2024
Best Places to Work icon 2025
Best Places to Work icon 2026

Voted one of San Diego Business Journal’s Best Places to Work four years in a row.